AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
-49.68%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$44M
AUM Growth
+$44M
(-60%)
Cap. Flow
-$4.06M
Cap. Flow
% of AUM
-9.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Cogent Biosciences
COGT
|
$4.06M |
Sector Composition
| 1 | Communication Services | 69.03% |
| 2 | Healthcare | 30.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Skillz
SKLZ
$135M
| $28.4M | 64.55% | 22,909,859 | – | – |
|
|
SURF
2
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $4.83M | 10.98% | 2,945,453 | – | – |
|
|
3
Cogent Biosciences
COGT
$1.69B
| $4.21M | 9.57% | 466,832 -450,000 | -49% | -$4.06M |
|
4
Synlogic
SYBX
$17M
| $3.05M | 6.93% | 2,651,963 | – | – |
|
5
Snap
SNAP
$12.1B
| $1.97M | 4.48% | 150,160 | – | – |
|
6
Spero Therapeutics
SPRO
$116M
| $1.02M | 2.32% | 1,376,968 | – | – |
|
7
Intellia Therapeutics
NTLA
$1.22B
| $518K | 1.18% | 10,000 | – | – |
|